Can-Fite BioPharma Ltd.
CANF
$0.53
-$0.04-6.81%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.80M | -8.34M | -7.88M | -5.92M | -- |
| Total Depreciation and Amortization | 29.00K | 18.00K | 7.00K | 4.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 455.00K | 479.00K | 503.00K | 436.50K | -- |
| Change in Net Operating Assets | -38.00K | -152.50K | -267.00K | -358.50K | -- |
| Cash from Operations | -8.35M | -8.00M | -7.64M | -5.84M | -- |
| Capital Expenditure | -2.00K | -3.50K | -5.00K | -4.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 750.00K | 1.50M | 3.00M | -- |
| Cash from Investing | -2.00K | 746.50K | 1.50M | 3.00M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.60M | 8.91M | 7.22M | 3.61M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -512.00K | -512.00K | -512.00K | -256.00K | -- |
| Cash from Financing | 10.08M | 8.40M | 6.71M | 3.36M | -- |
| Foreign Exchange rate Adjustments | 6.00K | -8.00K | -22.00K | -20.50K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | 1.14M | 547.00K | 494.00K | -- |